BusinessPetLife Pharmaceuticals Announces Son of World Famous Veterinarian & Pet Industry Innovator, Geoffrey Broderick, to Join the Company as the New PresidentBy Nasdaq OMXFeb 3, 2017, 1:00 PM UTC
BusinessVCA Inc. to Report Fourth Quarter 2016 Financial ResultsBy Nasdaq OMXJan 5, 2017, 11:26 PM UTC
BusinessPetLife Pharmaceuticals’ CEO Dr. Salvagno Provides White Paper on “Venenotherapy” While Preparing for FDA SubmissionBy Nasdaq OMXDec 6, 2016, 1:01 PM UTC
BusinessPetLife Pharmaceuticals’ CEO Dr. Salvagno Provides White Paper on “Venenotherapy” While Preparing for FDA SubmissionBy Nasdaq OMXDec 6, 2016, 1:01 PM UTC
BusinessPetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion Venom's Ability to Eradicate Cancer Cells as Continued Support for PetLife's pre- INAD Studies of Vitalzul™By Nasdaq OMXNov 15, 2016, 1:01 PM UTC
BusinessPetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion Venom's Ability to Eradicate Cancer Cells as Continued Support for PetLife's pre- INAD Studies of Vitalzul™By Nasdaq OMXNov 15, 2016, 1:01 PM UTC
BusinessNew Jersey veterinarians fear increased euthanasia of unwanted cats resulting from proposed surgical declawing banBy Nasdaq OMXNov 14, 2016, 6:15 PM UTC
